Lilly's Returning Cash to Shareholders With Generous Dividend, Stock Buybacks

NEW YORK ( TheStreet) -- Eli Lilly ( LLY) could be a solid investment.

The drug maker boasts a generous dividend yield, a substantial share buyback program, a new cancer drug and several promising drugs in development.

>>Read More: Warren Buffett’s Top 10 Dividend Stocks

Lilly -- whose shares traded Thursday morning at $63.16, up 16 cents -- has a dividend yield of 3.2%, compared with 1.9% for the Standard & Poor's 500 Index. The stock, which trades at 17.6 times this year's estimated earnings, has risen 23.5% so far this year, compared with an 8.2% gain for the S&P 500.

The company is the middle of $5 billion share buyback program which it launched last year.

In April, Lilly received approval for its stomach cancer drug, Cyramza. According to Bloomberg, analysts say the drug could generate $1 billion in annual sales. That would help offset the loss in sales from osteoporosis drug Evista, which lost patent protection in March, and the probable loss in sales from Cymbalta, a depression treatment that has been Lilly's top-selling drug but that will lose market exclusivity after this year,

>>Read More: Teva Dividend Could Be Cut by Bank of Israel’s Rate Cut

Last week, Lilly reported positive results for its late-stage studies of its psoriasis treatment, ixekizumab. It plans to submit the drug for regulatory review during the first half of next year.

On the diabetes front, in June, Abasria, an insulin made by Lilly that is similar to Sanofi's (SNY) Lantus, was backed by the European Medicines Agency's Committee for Medicinal Products for Human Use, paving the way for the drug's acceptance in the European Union. Sanofi is suing Lilly to block an introduction of Abasria in the U.S.

If you liked this article you might like

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Eli Lilly Still Looking for Lower Prices

Is Lilly Headed for the Valley?

Walmart, With Extra $10M Fund, Is Among 7 Giving for Hurricane Irma Relief